The novel investigational oral antibiotic gepotidacin was efficacious and safe for the treatment of uncomplicated urinary tract infections, with activity against common uropathogens. Gepotidacin, a ...
Phase 3 data reveal gepotidacin provides early symptom improvement and resolution comparable to that of nitrofurantoin in women with uncomplicated urinary tract infection, underscoring its potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results